News Coverage 11.06.19 Share on Twitter Share on Facebook Share on LinkedIn Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach Related Announcement, From Bench to Fireside Episode Eight: Robbie Majzner, MD Announcement, From Bench to Fireside Episode Seven: Evanna Mills, PhD Announcement, From Bench to Fireside Episode Six: Justin Eyquem, PhD